Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice

Yaoxue Xuebao

Volumn 42, Issue 1, 2007, Pages 66-70

  Xu, Rong ^a   Shi, Shao Jun ^a   Zhou, Shun Chang ^a   Zheng, Jian Wei ^b   Chen, Hui ^a   Zou, Sheng Quan ^b   Zeng, Fan Dian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

5 fluorouracil; In vivo distribution; Magnetic albumin deuto microsphere; Pharmacokinetics

Indexed keywords

ALBUMINOID; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; MICROSPHERE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; CHEMISTRY; DELAYED RELEASE FORMULATION; FEMALE; LIVER; LIVER TUMOR; MAGNETISM; MALE; METABOLISM; MOUSE; PATHOLOGY; RANDOMIZATION; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ALBUMINS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AREA UNDER CURVE; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; FEMALE; FLUOROURACIL; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETICS; MALE; MICE; MICROSPHERES; RANDOM ALLOCATION; TISSUE DISTRIBUTION;

EID: 33847761440     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Di Paolo A, Danesi R, Falcone A, et al. Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients [J]. Ann Oncol, 2001,12:1301-1306.
2. Schlemmer HP, Becker M, Bachert P, et al. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy [J]. Cancer Res, 1999,59:2363-2369.
3. Grem JL. 5-fluoropyrimidines [M]//Chabner BA, ed. Cancer Chemotherapy and Biotherapy. 2nd. Philadelphia: Lippincott Raven Publishers, 1996:146-211.
4. Lubbe AS, Alexion C, Bergemann C. Clinical application of magnetic drug targeting [J]. J Surg Res, 2001, 95:200-206.
5. Torchilin VP. Drug targeting [J]. Eur J Pharm Sci, 2000, 11:81-91.